nodes	percent_of_prediction	percent_of_DWPC	metapath
Celecoxib—ABCC4—Methotrexate—germ cell cancer	0.084	0.194	CbGbCtD
Celecoxib—PTGS2—Cisplatin—germ cell cancer	0.0761	0.176	CbGbCtD
Celecoxib—PTGS2—Etoposide—germ cell cancer	0.0748	0.173	CbGbCtD
Celecoxib—CYP2C9—Ifosfamide—germ cell cancer	0.0532	0.123	CbGbCtD
Celecoxib—ALB—Methotrexate—germ cell cancer	0.0311	0.072	CbGbCtD
Celecoxib—CYP3A4—Ifosfamide—germ cell cancer	0.0309	0.0714	CbGbCtD
Celecoxib—CYP2C9—Cisplatin—germ cell cancer	0.0259	0.0597	CbGbCtD
Celecoxib—CYP2D6—Vinblastine—germ cell cancer	0.0258	0.0596	CbGbCtD
Celecoxib—CYP3A4—Vinblastine—germ cell cancer	0.0164	0.0379	CbGbCtD
Celecoxib—CYP3A4—Etoposide—germ cell cancer	0.0148	0.0341	CbGbCtD
Celecoxib—CYP2C9—cardial valve—germ cell cancer	0.0099	0.0598	CbGeAlD
Celecoxib—CA6—ear—germ cell cancer	0.00803	0.0486	CbGeAlD
Celecoxib—PDPK1—trigeminal ganglion—germ cell cancer	0.00405	0.0245	CbGeAlD
Celecoxib—PDPK1—embryo—germ cell cancer	0.00392	0.0237	CbGeAlD
Celecoxib—MAPK14—blood vessel—germ cell cancer	0.00351	0.0212	CbGeAlD
Celecoxib—PDPK1—retina—germ cell cancer	0.00346	0.0209	CbGeAlD
Celecoxib—PDPK1—gonad—germ cell cancer	0.00266	0.0161	CbGeAlD
Celecoxib—PDPK1—uterus—germ cell cancer	0.00264	0.016	CbGeAlD
Celecoxib—PDPK1—pituitary gland—germ cell cancer	0.00259	0.0157	CbGeAlD
Celecoxib—MAPK14—neck—germ cell cancer	0.00251	0.0152	CbGeAlD
Celecoxib—PDPK1—medulla oblongata—germ cell cancer	0.0025	0.0151	CbGeAlD
Celecoxib—PDPK1—adrenal gland—germ cell cancer	0.00232	0.014	CbGeAlD
Celecoxib—PDPK1—midbrain—germ cell cancer	0.00229	0.0138	CbGeAlD
Celecoxib—PDPK1—spinal cord—germ cell cancer	0.00223	0.0135	CbGeAlD
Celecoxib—PDPK1—female gonad—germ cell cancer	0.00216	0.0131	CbGeAlD
Celecoxib—CYP2C9—urine—germ cell cancer	0.00213	0.0129	CbGeAlD
Celecoxib—MAPK14—embryo—germ cell cancer	0.00209	0.0127	CbGeAlD
Celecoxib—CA4—ganglion—germ cell cancer	0.00207	0.0125	CbGeAlD
Celecoxib—PDPK1—endocrine gland—germ cell cancer	0.00201	0.0121	CbGeAlD
Celecoxib—PDPK1—head—germ cell cancer	0.00198	0.012	CbGeAlD
Celecoxib—MAPK14—brainstem—germ cell cancer	0.00192	0.0116	CbGeAlD
Celecoxib—PDPK1—testis—germ cell cancer	0.00192	0.0116	CbGeAlD
Celecoxib—CA5A—endocrine gland—germ cell cancer	0.00189	0.0114	CbGeAlD
Celecoxib—PTGS2—appendage—germ cell cancer	0.00181	0.011	CbGeAlD
Celecoxib—PDPK1—cerebellum—germ cell cancer	0.00177	0.0107	CbGeAlD
Celecoxib—MAPK14—telencephalon—germ cell cancer	0.0017	0.0103	CbGeAlD
Celecoxib—CA14—telencephalon—germ cell cancer	0.00166	0.01	CbGeAlD
Celecoxib—CYP3A4—urine—germ cell cancer	0.00163	0.00984	CbGeAlD
Celecoxib—MAPK14—skin of body—germ cell cancer	0.00163	0.00982	CbGeAlD
Celecoxib—MAPK14—decidua—germ cell cancer	0.00161	0.00976	CbGeAlD
Celecoxib—CYP2D6—urine—germ cell cancer	0.0016	0.00968	CbGeAlD
Celecoxib—PTGS2—skin epidermis—germ cell cancer	0.00151	0.00912	CbGeAlD
Celecoxib—PDPK1—brain—germ cell cancer	0.00144	0.00868	CbGeAlD
Celecoxib—CA12—eye—germ cell cancer	0.00142	0.00857	CbGeAlD
Celecoxib—MAPK14—uterus—germ cell cancer	0.00141	0.00853	CbGeAlD
Celecoxib—PDPK1—lymph node—germ cell cancer	0.00139	0.00839	CbGeAlD
Celecoxib—MAPK14—pituitary gland—germ cell cancer	0.00139	0.00838	CbGeAlD
Celecoxib—CA14—medulla oblongata—germ cell cancer	0.0013	0.00787	CbGeAlD
Celecoxib—CA12—telencephalon—germ cell cancer	0.00129	0.00781	CbGeAlD
Celecoxib—MAPK14—adrenal gland—germ cell cancer	0.00124	0.00749	CbGeAlD
Celecoxib—CA14—adrenal gland—germ cell cancer	0.00121	0.00728	CbGeAlD
Celecoxib—CA6—head—germ cell cancer	0.0012	0.00725	CbGeAlD
Celecoxib—MAPK14—bone marrow—germ cell cancer	0.0012	0.00724	CbGeAlD
Celecoxib—MAPK14—spinal cord—germ cell cancer	0.00119	0.00721	CbGeAlD
Celecoxib—CA14—midbrain—germ cell cancer	0.00119	0.00719	CbGeAlD
Celecoxib—CA4—neck—germ cell cancer	0.00118	0.00713	CbGeAlD
Celecoxib—CA14—spinal cord—germ cell cancer	0.00116	0.00702	CbGeAlD
Celecoxib—MAPK14—female gonad—germ cell cancer	0.00116	0.00698	CbGeAlD
Celecoxib—CA9—endocrine gland—germ cell cancer	0.0011	0.00666	CbGeAlD
Celecoxib—PTGS2—endothelium—germ cell cancer	0.00109	0.00662	CbGeAlD
Celecoxib—MAPK14—endocrine gland—germ cell cancer	0.00107	0.00649	CbGeAlD
Celecoxib—MAPK14—head—germ cell cancer	0.00106	0.00641	CbGeAlD
Celecoxib—CA9—testis—germ cell cancer	0.00105	0.00635	CbGeAlD
Celecoxib—MAPK14—testis—germ cell cancer	0.00102	0.00619	CbGeAlD
Celecoxib—PTGS2—blood vessel—germ cell cancer	0.00101	0.0061	CbGeAlD
Celecoxib—CA2—neck—germ cell cancer	0.000978	0.00591	CbGeAlD
Celecoxib—CA9—cerebellum—germ cell cancer	0.00097	0.00586	CbGeAlD
Celecoxib—CA5B—gonad—germ cell cancer	0.000967	0.00585	CbGeAlD
Celecoxib—MAPK14—cerebellum—germ cell cancer	0.000946	0.00572	CbGeAlD
Celecoxib—CA14—cerebellum—germ cell cancer	0.00092	0.00556	CbGeAlD
Celecoxib—CA4—brainstem—germ cell cancer	0.000901	0.00545	CbGeAlD
Celecoxib—CA2—trigeminal ganglion—germ cell cancer	0.000845	0.00511	CbGeAlD
Celecoxib—CA5B—adrenal gland—germ cell cancer	0.000843	0.0051	CbGeAlD
Celecoxib—CA2—embryo—germ cell cancer	0.000816	0.00493	CbGeAlD
Celecoxib—CA12—endocrine gland—germ cell cancer	0.000815	0.00493	CbGeAlD
Celecoxib—CA12—head—germ cell cancer	0.000805	0.00486	CbGeAlD
Celecoxib—CA4—telencephalon—germ cell cancer	0.0008	0.00484	CbGeAlD
Celecoxib—MAPK14—brain—germ cell cancer	0.000768	0.00464	CbGeAlD
Celecoxib—CA14—brain—germ cell cancer	0.000748	0.00452	CbGeAlD
Celecoxib—CA2—brainstem—germ cell cancer	0.000747	0.00452	CbGeAlD
Celecoxib—MAPK14—lymph node—germ cell cancer	0.000743	0.00449	CbGeAlD
Celecoxib—CA5B—endocrine gland—germ cell cancer	0.000731	0.00442	CbGeAlD
Celecoxib—CA2—eye—germ cell cancer	0.000728	0.0044	CbGeAlD
Celecoxib—CA5B—head—germ cell cancer	0.000722	0.00436	CbGeAlD
Celecoxib—ABCC4—uterus—germ cell cancer	0.000722	0.00436	CbGeAlD
Celecoxib—ORM1—bone marrow—germ cell cancer	0.000721	0.00436	CbGeAlD
Celecoxib—CA2—retina—germ cell cancer	0.000721	0.00436	CbGeAlD
Celecoxib—ORM1—spinal cord—germ cell cancer	0.000718	0.00434	CbGeAlD
Celecoxib—CA5B—testis—germ cell cancer	0.000697	0.00421	CbGeAlD
Celecoxib—CA2—telencephalon—germ cell cancer	0.000663	0.00401	CbGeAlD
Celecoxib—ALB—adrenal gland—germ cell cancer	0.000654	0.00395	CbGeAlD
Celecoxib—CA4—pituitary gland—germ cell cancer	0.000651	0.00394	CbGeAlD
Celecoxib—ORM1—endocrine gland—germ cell cancer	0.000647	0.00391	CbGeAlD
Celecoxib—CA2—skin of body—germ cell cancer	0.000633	0.00383	CbGeAlD
Celecoxib—ABCC4—adrenal gland—germ cell cancer	0.000633	0.00383	CbGeAlD
Celecoxib—CA2—decidua—germ cell cancer	0.000629	0.0038	CbGeAlD
Celecoxib—CA4—medulla oblongata—germ cell cancer	0.000629	0.0038	CbGeAlD
Celecoxib—PTGS2—trigeminal ganglion—germ cell cancer	0.000624	0.00377	CbGeAlD
Celecoxib—ABCC4—bone marrow—germ cell cancer	0.000612	0.0037	CbGeAlD
Celecoxib—PTGS2—embryo—germ cell cancer	0.000602	0.00364	CbGeAlD
Celecoxib—ABCC4—female gonad—germ cell cancer	0.00059	0.00357	CbGeAlD
Celecoxib—CA12—brain—germ cell cancer	0.000583	0.00352	CbGeAlD
Celecoxib—CA4—adrenal gland—germ cell cancer	0.000582	0.00352	CbGeAlD
Celecoxib—CA4—midbrain—germ cell cancer	0.000574	0.00347	CbGeAlD
Celecoxib—CA4—bone marrow—germ cell cancer	0.000563	0.0034	CbGeAlD
Celecoxib—CA4—spinal cord—germ cell cancer	0.000561	0.00339	CbGeAlD
Celecoxib—ABCC4—endocrine gland—germ cell cancer	0.000549	0.00332	CbGeAlD
Celecoxib—CA4—female gonad—germ cell cancer	0.000543	0.00328	CbGeAlD
Celecoxib—ABCC4—head—germ cell cancer	0.000542	0.00328	CbGeAlD
Celecoxib—ALB—testis—germ cell cancer	0.000541	0.00327	CbGeAlD
Celecoxib—CA2—pituitary gland—germ cell cancer	0.00054	0.00326	CbGeAlD
Celecoxib—ABCC4—testis—germ cell cancer	0.000523	0.00316	CbGeAlD
Celecoxib—CA5B—brain—germ cell cancer	0.000523	0.00316	CbGeAlD
Celecoxib—CA2—medulla oblongata—germ cell cancer	0.000521	0.00315	CbGeAlD
Celecoxib—CA5B—lymph node—germ cell cancer	0.000505	0.00305	CbGeAlD
Celecoxib—CA4—endocrine gland—germ cell cancer	0.000505	0.00305	CbGeAlD
Celecoxib—CA4—head—germ cell cancer	0.000498	0.00301	CbGeAlD
Celecoxib—PTGS2—telencephalon—germ cell cancer	0.00049	0.00296	CbGeAlD
Celecoxib—CA2—adrenal gland—germ cell cancer	0.000482	0.00292	CbGeAlD
Celecoxib—CA4—testis—germ cell cancer	0.000481	0.00291	CbGeAlD
Celecoxib—CA2—midbrain—germ cell cancer	0.000476	0.00288	CbGeAlD
Celecoxib—CYP2D6—brainstem—germ cell cancer	0.000475	0.00287	CbGeAlD
Celecoxib—PTGS2—skin of body—germ cell cancer	0.000467	0.00282	CbGeAlD
Celecoxib—CA2—bone marrow—germ cell cancer	0.000467	0.00282	CbGeAlD
Celecoxib—CA2—spinal cord—germ cell cancer	0.000465	0.00281	CbGeAlD
Celecoxib—CA2—female gonad—germ cell cancer	0.00045	0.00272	CbGeAlD
Celecoxib—ORM1—lymph node—germ cell cancer	0.000447	0.0027	CbGeAlD
Celecoxib—CA4—cerebellum—germ cell cancer	0.000444	0.00269	CbGeAlD
Celecoxib—CYP2D6—telencephalon—germ cell cancer	0.000421	0.00255	CbGeAlD
Celecoxib—CA2—endocrine gland—germ cell cancer	0.000418	0.00253	CbGeAlD
Celecoxib—CA2—head—germ cell cancer	0.000413	0.0025	CbGeAlD
Celecoxib—PTGS2—uterus—germ cell cancer	0.000406	0.00245	CbGeAlD
Celecoxib—ALB—brain—germ cell cancer	0.000406	0.00245	CbGeAlD
Celecoxib—CA2—testis—germ cell cancer	0.000399	0.00241	CbGeAlD
Celecoxib—PTGS2—pituitary gland—germ cell cancer	0.000399	0.00241	CbGeAlD
Celecoxib—ABCC4—brain—germ cell cancer	0.000393	0.00237	CbGeAlD
Celecoxib—ALB—lymph node—germ cell cancer	0.000392	0.00237	CbGeAlD
Celecoxib—PTGS2—medulla oblongata—germ cell cancer	0.000385	0.00233	CbGeAlD
Celecoxib—Vertigo—Ifosfamide—germ cell cancer	0.000382	0.00142	CcSEcCtD
Celecoxib—Urinary tract disorder—Etoposide—germ cell cancer	0.000381	0.00141	CcSEcCtD
Celecoxib—Leukopenia—Ifosfamide—germ cell cancer	0.000381	0.00141	CcSEcCtD
Celecoxib—Photosensitivity—Methotrexate—germ cell cancer	0.000381	0.00141	CcSEcCtD
Celecoxib—Immune system disorder—Cisplatin—germ cell cancer	0.00038	0.00141	CcSEcCtD
Celecoxib—Abdominal pain—Vinblastine—germ cell cancer	0.00038	0.00141	CcSEcCtD
Celecoxib—Mediastinal disorder—Cisplatin—germ cell cancer	0.00038	0.00141	CcSEcCtD
Celecoxib—ABCC4—lymph node—germ cell cancer	0.000379	0.00229	CbGeAlD
Celecoxib—Oedema—Dactinomycin—germ cell cancer	0.000379	0.0014	CcSEcCtD
Celecoxib—Urethral disorder—Etoposide—germ cell cancer	0.000378	0.0014	CcSEcCtD
Celecoxib—Infection—Dactinomycin—germ cell cancer	0.000376	0.0014	CcSEcCtD
Celecoxib—Arrhythmia—Cisplatin—germ cell cancer	0.000376	0.00139	CcSEcCtD
Celecoxib—Palpitations—Ifosfamide—germ cell cancer	0.000376	0.00139	CcSEcCtD
Celecoxib—Alopecia—Cisplatin—germ cell cancer	0.000372	0.00138	CcSEcCtD
Celecoxib—Hepatic failure—Methotrexate—germ cell cancer	0.000372	0.00138	CcSEcCtD
Celecoxib—Cough—Ifosfamide—germ cell cancer	0.000371	0.00138	CcSEcCtD
Celecoxib—Thrombocytopenia—Dactinomycin—germ cell cancer	0.000371	0.00137	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.00037	0.00137	CcSEcCtD
Celecoxib—CA2—cerebellum—germ cell cancer	0.000369	0.00223	CbGeAlD
Celecoxib—Hypertension—Ifosfamide—germ cell cancer	0.000367	0.00136	CcSEcCtD
Celecoxib—Erythema multiforme—Etoposide—germ cell cancer	0.000365	0.00135	CcSEcCtD
Celecoxib—Paraesthesia—Bleomycin—germ cell cancer	0.000365	0.00135	CcSEcCtD
Celecoxib—Dyspnoea—Bleomycin—germ cell cancer	0.000362	0.00134	CcSEcCtD
Celecoxib—Chest pain—Ifosfamide—germ cell cancer	0.000362	0.00134	CcSEcCtD
Celecoxib—Arthralgia—Ifosfamide—germ cell cancer	0.000362	0.00134	CcSEcCtD
Celecoxib—Myalgia—Ifosfamide—germ cell cancer	0.000362	0.00134	CcSEcCtD
Celecoxib—Renal failure acute—Methotrexate—germ cell cancer	0.000362	0.00134	CcSEcCtD
Celecoxib—Flatulence—Cisplatin—germ cell cancer	0.000361	0.00134	CcSEcCtD
Celecoxib—Anorexia—Dactinomycin—germ cell cancer	0.000361	0.00134	CcSEcCtD
Celecoxib—CA4—brain—germ cell cancer	0.000361	0.00218	CbGeAlD
Celecoxib—Eye disorder—Etoposide—germ cell cancer	0.000361	0.00134	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.00036	0.00133	CcSEcCtD
Celecoxib—Flushing—Etoposide—germ cell cancer	0.000358	0.00133	CcSEcCtD
Celecoxib—Cardiac disorder—Etoposide—germ cell cancer	0.000358	0.00133	CcSEcCtD
Celecoxib—PTGS2—adrenal gland—germ cell cancer	0.000356	0.00215	CbGeAlD
Celecoxib—Hypersensitivity—Vinblastine—germ cell cancer	0.000354	0.00131	CcSEcCtD
Celecoxib—Dermatitis exfoliative—Methotrexate—germ cell cancer	0.000354	0.00131	CcSEcCtD
Celecoxib—CYP2C9—endocrine gland—germ cell cancer	0.000354	0.00214	CbGeAlD
Celecoxib—Decreased appetite—Bleomycin—germ cell cancer	0.000353	0.00131	CcSEcCtD
Celecoxib—Muscle spasms—Cisplatin—germ cell cancer	0.000353	0.00131	CcSEcCtD
Celecoxib—PTGS2—midbrain—germ cell cancer	0.000352	0.00213	CbGeAlD
Celecoxib—Angiopathy—Etoposide—germ cell cancer	0.00035	0.0013	CcSEcCtD
Celecoxib—Confusional state—Ifosfamide—germ cell cancer	0.00035	0.0013	CcSEcCtD
Celecoxib—CA4—lymph node—germ cell cancer	0.000349	0.00211	CbGeAlD
Celecoxib—Immune system disorder—Etoposide—germ cell cancer	0.000349	0.00129	CcSEcCtD
Celecoxib—Mediastinal disorder—Etoposide—germ cell cancer	0.000348	0.00129	CcSEcCtD
Celecoxib—Oedema—Ifosfamide—germ cell cancer	0.000347	0.00129	CcSEcCtD
Celecoxib—Anaphylactic shock—Ifosfamide—germ cell cancer	0.000347	0.00129	CcSEcCtD
Celecoxib—Vision blurred—Cisplatin—germ cell cancer	0.000346	0.00128	CcSEcCtD
Celecoxib—Anaphylactoid reaction—Methotrexate—germ cell cancer	0.000345	0.00128	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.000345	0.00128	CcSEcCtD
Celecoxib—Asthenia—Vinblastine—germ cell cancer	0.000345	0.00128	CcSEcCtD
Celecoxib—Infection—Ifosfamide—germ cell cancer	0.000345	0.00128	CcSEcCtD
Celecoxib—PTGS2—bone marrow—germ cell cancer	0.000345	0.00208	CbGeAlD
Celecoxib—PTGS2—spinal cord—germ cell cancer	0.000343	0.00207	CbGeAlD
Celecoxib—Alopecia—Etoposide—germ cell cancer	0.000341	0.00126	CcSEcCtD
Celecoxib—Cerebrovascular accident—Methotrexate—germ cell cancer	0.000341	0.00126	CcSEcCtD
Celecoxib—Nervous system disorder—Ifosfamide—germ cell cancer	0.00034	0.00126	CcSEcCtD
Celecoxib—Thrombocytopenia—Ifosfamide—germ cell cancer	0.00034	0.00126	CcSEcCtD
Celecoxib—Anaemia—Cisplatin—germ cell cancer	0.000339	0.00126	CcSEcCtD
Celecoxib—Skin disorder—Ifosfamide—germ cell cancer	0.000337	0.00125	CcSEcCtD
Celecoxib—Hyperhidrosis—Ifosfamide—germ cell cancer	0.000336	0.00124	CcSEcCtD
Celecoxib—Feeling abnormal—Bleomycin—germ cell cancer	0.000335	0.00124	CcSEcCtD
Celecoxib—Osteoarthritis—Methotrexate—germ cell cancer	0.000334	0.00124	CcSEcCtD
Celecoxib—PTGS2—female gonad—germ cell cancer	0.000332	0.00201	CbGeAlD
Celecoxib—Anorexia—Ifosfamide—germ cell cancer	0.000331	0.00123	CcSEcCtD
Celecoxib—Decreased appetite—Dactinomycin—germ cell cancer	0.000329	0.00122	CcSEcCtD
Celecoxib—Diarrhoea—Vinblastine—germ cell cancer	0.000329	0.00122	CcSEcCtD
Celecoxib—Dysgeusia—Etoposide—germ cell cancer	0.000329	0.00122	CcSEcCtD
Celecoxib—Leukopenia—Cisplatin—germ cell cancer	0.000328	0.00122	CcSEcCtD
Celecoxib—Fatigue—Dactinomycin—germ cell cancer	0.000327	0.00121	CcSEcCtD
Celecoxib—Back pain—Etoposide—germ cell cancer	0.000325	0.0012	CcSEcCtD
Celecoxib—Muscle spasms—Etoposide—germ cell cancer	0.000323	0.0012	CcSEcCtD
Celecoxib—Urticaria—Bleomycin—germ cell cancer	0.000323	0.0012	CcSEcCtD
Celecoxib—Body temperature increased—Bleomycin—germ cell cancer	0.000321	0.00119	CcSEcCtD
Celecoxib—Dizziness—Vinblastine—germ cell cancer	0.000318	0.00118	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.000316	0.00117	CcSEcCtD
Celecoxib—Ataxia—Methotrexate—germ cell cancer	0.000314	0.00116	CcSEcCtD
Celecoxib—Myalgia—Cisplatin—germ cell cancer	0.000312	0.00116	CcSEcCtD
Celecoxib—Feeling abnormal—Dactinomycin—germ cell cancer	0.000312	0.00116	CcSEcCtD
Celecoxib—Paraesthesia—Ifosfamide—germ cell cancer	0.000312	0.00116	CcSEcCtD
Celecoxib—Anxiety—Cisplatin—germ cell cancer	0.000311	0.00115	CcSEcCtD
Celecoxib—Anaemia—Etoposide—germ cell cancer	0.000311	0.00115	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.00031	0.00115	CcSEcCtD
Celecoxib—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.00031	0.00115	CcSEcCtD
Celecoxib—Dyspnoea—Ifosfamide—germ cell cancer	0.000309	0.00115	CcSEcCtD
Celecoxib—PTGS2—endocrine gland—germ cell cancer	0.000309	0.00187	CbGeAlD
Celecoxib—Somnolence—Ifosfamide—germ cell cancer	0.000309	0.00114	CcSEcCtD
Celecoxib—Liver function test abnormal—Methotrexate—germ cell cancer	0.000308	0.00114	CcSEcCtD
Celecoxib—Vomiting—Vinblastine—germ cell cancer	0.000306	0.00113	CcSEcCtD
Celecoxib—PTGS2—head—germ cell cancer	0.000305	0.00184	CbGeAlD
Celecoxib—Breast disorder—Methotrexate—germ cell cancer	0.000302	0.00112	CcSEcCtD
Celecoxib—Vertigo—Etoposide—germ cell cancer	0.000302	0.00112	CcSEcCtD
Celecoxib—Decreased appetite—Ifosfamide—germ cell cancer	0.000302	0.00112	CcSEcCtD
Celecoxib—Headache—Vinblastine—germ cell cancer	0.000301	0.00112	CcSEcCtD
Celecoxib—Toxic epidermal necrolysis—Methotrexate—germ cell cancer	0.000301	0.00112	CcSEcCtD
Celecoxib—Leukopenia—Etoposide—germ cell cancer	0.000301	0.00111	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.0003	0.00111	CcSEcCtD
Celecoxib—Body temperature increased—Dactinomycin—germ cell cancer	0.000299	0.00111	CcSEcCtD
Celecoxib—Abdominal pain—Dactinomycin—germ cell cancer	0.000299	0.00111	CcSEcCtD
Celecoxib—CA2—brain—germ cell cancer	0.000299	0.00181	CbGeAlD
Celecoxib—Fatigue—Ifosfamide—germ cell cancer	0.000299	0.00111	CcSEcCtD
Celecoxib—Anaphylactic shock—Cisplatin—germ cell cancer	0.000299	0.00111	CcSEcCtD
Celecoxib—Oedema—Cisplatin—germ cell cancer	0.000299	0.00111	CcSEcCtD
Celecoxib—Hypersensitivity—Bleomycin—germ cell cancer	0.000299	0.00111	CcSEcCtD
Celecoxib—Infection—Cisplatin—germ cell cancer	0.000297	0.0011	CcSEcCtD
Celecoxib—Constipation—Ifosfamide—germ cell cancer	0.000297	0.0011	CcSEcCtD
Celecoxib—Loss of consciousness—Etoposide—germ cell cancer	0.000295	0.00109	CcSEcCtD
Celecoxib—Nervous system disorder—Cisplatin—germ cell cancer	0.000293	0.00109	CcSEcCtD
Celecoxib—Cough—Etoposide—germ cell cancer	0.000293	0.00109	CcSEcCtD
Celecoxib—Thrombocytopenia—Cisplatin—germ cell cancer	0.000293	0.00109	CcSEcCtD
Celecoxib—Tachycardia—Cisplatin—germ cell cancer	0.000292	0.00108	CcSEcCtD
Celecoxib—Asthenia—Bleomycin—germ cell cancer	0.000291	0.00108	CcSEcCtD
Celecoxib—Skin disorder—Cisplatin—germ cell cancer	0.000291	0.00108	CcSEcCtD
Celecoxib—Hypertension—Etoposide—germ cell cancer	0.00029	0.00108	CcSEcCtD
Celecoxib—Hyperhidrosis—Cisplatin—germ cell cancer	0.000289	0.00107	CcSEcCtD
Celecoxib—CA2—lymph node—germ cell cancer	0.000289	0.00175	CbGeAlD
Celecoxib—Pruritus—Bleomycin—germ cell cancer	0.000287	0.00107	CcSEcCtD
Celecoxib—Feeling abnormal—Ifosfamide—germ cell cancer	0.000286	0.00106	CcSEcCtD
Celecoxib—Chest pain—Etoposide—germ cell cancer	0.000286	0.00106	CcSEcCtD
Celecoxib—Eosinophilia—Methotrexate—germ cell cancer	0.000286	0.00106	CcSEcCtD
Celecoxib—Nausea—Vinblastine—germ cell cancer	0.000286	0.00106	CcSEcCtD
Celecoxib—CYP2D6—female gonad—germ cell cancer	0.000286	0.00173	CbGeAlD
Celecoxib—Anorexia—Cisplatin—germ cell cancer	0.000285	0.00106	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.000284	0.00105	CcSEcCtD
Celecoxib—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000284	0.00105	CcSEcCtD
Celecoxib—Pancreatitis—Methotrexate—germ cell cancer	0.000283	0.00105	CcSEcCtD
Celecoxib—Hypersensitivity—Dactinomycin—germ cell cancer	0.000279	0.00103	CcSEcCtD
Celecoxib—Confusional state—Etoposide—germ cell cancer	0.000276	0.00102	CcSEcCtD
Celecoxib—Urticaria—Ifosfamide—germ cell cancer	0.000276	0.00102	CcSEcCtD
Celecoxib—Abdominal pain—Ifosfamide—germ cell cancer	0.000274	0.00102	CcSEcCtD
Celecoxib—Body temperature increased—Ifosfamide—germ cell cancer	0.000274	0.00102	CcSEcCtD
Celecoxib—Pancytopenia—Methotrexate—germ cell cancer	0.000274	0.00102	CcSEcCtD
Celecoxib—Anaphylactic shock—Etoposide—germ cell cancer	0.000274	0.00102	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.000273	0.00101	CcSEcCtD
Celecoxib—Infection—Etoposide—germ cell cancer	0.000272	0.00101	CcSEcCtD
Celecoxib—PTGS2—cerebellum—germ cell cancer	0.000272	0.00164	CbGeAlD
Celecoxib—Asthenia—Dactinomycin—germ cell cancer	0.000272	0.00101	CcSEcCtD
Celecoxib—Dysuria—Methotrexate—germ cell cancer	0.00027	0.001	CcSEcCtD
Celecoxib—CYP3A4—endocrine gland—germ cell cancer	0.00027	0.00163	CbGeAlD
Celecoxib—Paraesthesia—Cisplatin—germ cell cancer	0.000269	0.000996	CcSEcCtD
Celecoxib—Thrombocytopenia—Etoposide—germ cell cancer	0.000268	0.000995	CcSEcCtD
Celecoxib—Upper respiratory tract infection—Methotrexate—germ cell cancer	0.000268	0.000995	CcSEcCtD
Celecoxib—Tachycardia—Etoposide—germ cell cancer	0.000268	0.000992	CcSEcCtD
Celecoxib—Dyspnoea—Cisplatin—germ cell cancer	0.000267	0.000989	CcSEcCtD
Celecoxib—Skin disorder—Etoposide—germ cell cancer	0.000266	0.000987	CcSEcCtD
Celecoxib—CYP2D6—endocrine gland—germ cell cancer	0.000266	0.00161	CbGeAlD
Celecoxib—Hyperhidrosis—Etoposide—germ cell cancer	0.000265	0.000982	CcSEcCtD
Celecoxib—Photosensitivity reaction—Methotrexate—germ cell cancer	0.000264	0.000977	CcSEcCtD
Celecoxib—CYP2D6—head—germ cell cancer	0.000262	0.00158	CbGeAlD
Celecoxib—Anorexia—Etoposide—germ cell cancer	0.000261	0.000969	CcSEcCtD
Celecoxib—MAPK14—Signaling mediated by p38-alpha and p38-beta—TP53—germ cell cancer	0.000261	0.00198	CbGpPWpGaD
Celecoxib—Decreased appetite—Cisplatin—germ cell cancer	0.00026	0.000964	CcSEcCtD
Celecoxib—Diarrhoea—Dactinomycin—germ cell cancer	0.000259	0.000961	CcSEcCtD
Celecoxib—Pneumonia—Methotrexate—germ cell cancer	0.000259	0.00096	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000258	0.000958	CcSEcCtD
Celecoxib—Vomiting—Bleomycin—germ cell cancer	0.000258	0.000957	CcSEcCtD
Celecoxib—CA14—Metabolism—SLC22A3—germ cell cancer	0.000258	0.00196	CbGpPWpGaD
Celecoxib—Infestation NOS—Methotrexate—germ cell cancer	0.000257	0.000954	CcSEcCtD
Celecoxib—Infestation—Methotrexate—germ cell cancer	0.000257	0.000954	CcSEcCtD
Celecoxib—Rash—Bleomycin—germ cell cancer	0.000256	0.000949	CcSEcCtD
Celecoxib—Dermatitis—Bleomycin—germ cell cancer	0.000256	0.000948	CcSEcCtD
Celecoxib—Hypersensitivity—Ifosfamide—germ cell cancer	0.000256	0.000948	CcSEcCtD
Celecoxib—MAPK14—Trk receptor signaling mediated by the MAPK pathway—HRAS—germ cell cancer	0.000255	0.00194	CbGpPWpGaD
Celecoxib—MAPK14—p38 MAPK Signaling Pathway—HRAS—germ cell cancer	0.000255	0.00194	CbGpPWpGaD
Celecoxib—MAPK14—Signalling to RAS—HRAS—germ cell cancer	0.000255	0.00194	CbGpPWpGaD
Celecoxib—Stevens-Johnson syndrome—Methotrexate—germ cell cancer	0.000255	0.000946	CcSEcCtD
Celecoxib—CA6—Metabolism—SLC2A3—germ cell cancer	0.000255	0.00194	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—SLC2A3—germ cell cancer	0.000255	0.00194	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways in Glioblastoma—TP53—germ cell cancer	0.000254	0.00193	CbGpPWpGaD
Celecoxib—CYP2D6—testis—germ cell cancer	0.000253	0.00153	CbGeAlD
Celecoxib—CA5A—Metabolism—SLC22A3—germ cell cancer	0.000251	0.00191	CbGpPWpGaD
Celecoxib—CA6—Metabolism—SLC22A3—germ cell cancer	0.000251	0.00191	CbGpPWpGaD
Celecoxib—MAPK14—TSLP Signaling Pathway—MYC—germ cell cancer	0.000251	0.0019	CbGpPWpGaD
Celecoxib—MAPK14—IL6-mediated signaling events—MYC—germ cell cancer	0.000251	0.0019	CbGpPWpGaD
Celecoxib—Stomatitis—Methotrexate—germ cell cancer	0.000251	0.00093	CcSEcCtD
Celecoxib—Conjunctivitis—Methotrexate—germ cell cancer	0.00025	0.000928	CcSEcCtD
Celecoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—FGF4—germ cell cancer	0.00025	0.00189	CbGpPWpGaD
Celecoxib—Asthenia—Ifosfamide—germ cell cancer	0.000249	0.000923	CcSEcCtD
Celecoxib—PDPK1—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—HRAS—germ cell cancer	0.000248	0.00188	CbGpPWpGaD
Celecoxib—Feeling abnormal—Cisplatin—germ cell cancer	0.000247	0.000914	CcSEcCtD
Celecoxib—Paraesthesia—Etoposide—germ cell cancer	0.000246	0.000913	CcSEcCtD
Celecoxib—Pruritus—Ifosfamide—germ cell cancer	0.000246	0.00091	CcSEcCtD
Celecoxib—Haematuria—Methotrexate—germ cell cancer	0.000246	0.00091	CcSEcCtD
Celecoxib—Dyspnoea—Etoposide—germ cell cancer	0.000244	0.000906	CcSEcCtD
Celecoxib—MAPK14—Amyotrophic lateral sclerosis (ALS)—TP53—germ cell cancer	0.000244	0.00185	CbGpPWpGaD
Celecoxib—Somnolence—Etoposide—germ cell cancer	0.000244	0.000903	CcSEcCtD
Celecoxib—Hepatobiliary disease—Methotrexate—germ cell cancer	0.000244	0.000903	CcSEcCtD
Celecoxib—PDPK1—Signaling Pathways in Glioblastoma—HRAS—germ cell cancer	0.000243	0.00184	CbGpPWpGaD
Celecoxib—Epistaxis—Methotrexate—germ cell cancer	0.000243	0.0009	CcSEcCtD
Celecoxib—MAPK14—Cellular Senescence—H2AFZ—germ cell cancer	0.000242	0.00183	CbGpPWpGaD
Celecoxib—Nausea—Bleomycin—germ cell cancer	0.000241	0.000894	CcSEcCtD
Celecoxib—Vomiting—Dactinomycin—germ cell cancer	0.000241	0.000893	CcSEcCtD
Celecoxib—Agranulocytosis—Methotrexate—germ cell cancer	0.00024	0.000891	CcSEcCtD
Celecoxib—MAPK14—Developmental Biology—KLF4—germ cell cancer	0.00024	0.00182	CbGpPWpGaD
Celecoxib—Rash—Dactinomycin—germ cell cancer	0.000239	0.000885	CcSEcCtD
Celecoxib—Decreased appetite—Etoposide—germ cell cancer	0.000238	0.000883	CcSEcCtD
Celecoxib—CA5B—Metabolism—SLC2A3—germ cell cancer	0.000238	0.00181	CbGpPWpGaD
Celecoxib—Diarrhoea—Ifosfamide—germ cell cancer	0.000238	0.00088	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000237	0.000877	CcSEcCtD
Celecoxib—Body temperature increased—Cisplatin—germ cell cancer	0.000237	0.000877	CcSEcCtD
Celecoxib—Fatigue—Etoposide—germ cell cancer	0.000236	0.000876	CcSEcCtD
Celecoxib—PDPK1—IRS-mediated signalling—HRAS—germ cell cancer	0.000236	0.00179	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—CD9—germ cell cancer	0.000235	0.00178	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—SLC22A3—germ cell cancer	0.000235	0.00178	CbGpPWpGaD
Celecoxib—Constipation—Etoposide—germ cell cancer	0.000234	0.000869	CcSEcCtD
Celecoxib—CYP2D6—cerebellum—germ cell cancer	0.000234	0.00141	CbGeAlD
Celecoxib—MAPK14—CXCR3-mediated signaling events—HRAS—germ cell cancer	0.000234	0.00177	CbGpPWpGaD
Celecoxib—Haemoglobin—Methotrexate—germ cell cancer	0.000232	0.000861	CcSEcCtD
Celecoxib—Hepatitis—Methotrexate—germ cell cancer	0.000231	0.000857	CcSEcCtD
Celecoxib—Haemorrhage—Methotrexate—germ cell cancer	0.000231	0.000857	CcSEcCtD
Celecoxib—PDPK1—IRS-related events—HRAS—germ cell cancer	0.00023	0.00174	CbGpPWpGaD
Celecoxib—Dizziness—Ifosfamide—germ cell cancer	0.00023	0.000851	CcSEcCtD
Celecoxib—Pharyngitis—Methotrexate—germ cell cancer	0.000229	0.00085	CcSEcCtD
Celecoxib—Urinary tract disorder—Methotrexate—germ cell cancer	0.000228	0.000846	CcSEcCtD
Celecoxib—PDPK1—IRS-related events triggered by IGF1R—HRAS—germ cell cancer	0.000228	0.00173	CbGpPWpGaD
Celecoxib—Urethral disorder—Methotrexate—germ cell cancer	0.000227	0.00084	CcSEcCtD
Celecoxib—Feeling abnormal—Etoposide—germ cell cancer	0.000226	0.000837	CcSEcCtD
Celecoxib—PDPK1—TCR Signaling Pathway—HRAS—germ cell cancer	0.000226	0.00171	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by NGF—FGFR3—germ cell cancer	0.000226	0.00171	CbGpPWpGaD
Celecoxib—Nausea—Dactinomycin—germ cell cancer	0.000225	0.000834	CcSEcCtD
Celecoxib—MAPK14—IL2-mediated signaling events—MYC—germ cell cancer	0.000225	0.0017	CbGpPWpGaD
Celecoxib—Gastrointestinal pain—Etoposide—germ cell cancer	0.000224	0.000831	CcSEcCtD
Celecoxib—PDPK1—IGF1R signaling cascade—HRAS—germ cell cancer	0.000222	0.00168	CbGpPWpGaD
Celecoxib—PDPK1—Insulin receptor signalling cascade—HRAS—germ cell cancer	0.000222	0.00168	CbGpPWpGaD
Celecoxib—PTGS2—brain—germ cell cancer	0.000221	0.00134	CbGeAlD
Celecoxib—CA12—Metabolism—SLC2A3—germ cell cancer	0.000221	0.00167	CbGpPWpGaD
Celecoxib—Vomiting—Ifosfamide—germ cell cancer	0.000221	0.000818	CcSEcCtD
Celecoxib—Hypersensitivity—Cisplatin—germ cell cancer	0.00022	0.000817	CcSEcCtD
Celecoxib—Rash—Ifosfamide—germ cell cancer	0.000219	0.000811	CcSEcCtD
Celecoxib—Dermatitis—Ifosfamide—germ cell cancer	0.000219	0.000811	CcSEcCtD
Celecoxib—Erythema multiforme—Methotrexate—germ cell cancer	0.000219	0.00081	CcSEcCtD
Celecoxib—Urticaria—Etoposide—germ cell cancer	0.000218	0.000807	CcSEcCtD
Celecoxib—CA12—Metabolism—SLC22A3—germ cell cancer	0.000217	0.00165	CbGpPWpGaD
Celecoxib—Abdominal pain—Etoposide—germ cell cancer	0.000217	0.000803	CcSEcCtD
Celecoxib—Body temperature increased—Etoposide—germ cell cancer	0.000217	0.000803	CcSEcCtD
Celecoxib—Eye disorder—Methotrexate—germ cell cancer	0.000216	0.000801	CcSEcCtD
Celecoxib—Tinnitus—Methotrexate—germ cell cancer	0.000216	0.000799	CcSEcCtD
Celecoxib—Asthenia—Cisplatin—germ cell cancer	0.000215	0.000796	CcSEcCtD
Celecoxib—Cardiac disorder—Methotrexate—germ cell cancer	0.000215	0.000795	CcSEcCtD
Celecoxib—PTGS2—lymph node—germ cell cancer	0.000214	0.00129	CbGeAlD
Celecoxib—PDPK1—B Cell Receptor Signaling Pathway—HRAS—germ cell cancer	0.000213	0.00161	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—FGF4—germ cell cancer	0.000211	0.0016	CbGpPWpGaD
Celecoxib—CA14—Metabolism—CRABP1—germ cell cancer	0.00021	0.0016	CbGpPWpGaD
Celecoxib—Angiopathy—Methotrexate—germ cell cancer	0.00021	0.000777	CcSEcCtD
Celecoxib—ABCC4—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000209	0.00159	CbGpPWpGaD
Celecoxib—Immune system disorder—Methotrexate—germ cell cancer	0.000209	0.000774	CcSEcCtD
Celecoxib—Mediastinal disorder—Methotrexate—germ cell cancer	0.000208	0.000772	CcSEcCtD
Celecoxib—MAPK14—Signalling to ERKs—HRAS—germ cell cancer	0.000208	0.00158	CbGpPWpGaD
Celecoxib—PDPK1—Integrin-mediated Cell Adhesion—HRAS—germ cell cancer	0.000207	0.00157	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by NGF—KIT—germ cell cancer	0.000207	0.00157	CbGpPWpGaD
Celecoxib—ABCC4—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000206	0.00156	CbGpPWpGaD
Celecoxib—Nausea—Ifosfamide—germ cell cancer	0.000206	0.000764	CcSEcCtD
Celecoxib—ALB—Platelet activation, signaling and aggregation—CD9—germ cell cancer	0.000206	0.00156	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—CD9—germ cell cancer	0.000206	0.00156	CbGpPWpGaD
Celecoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—KITLG—germ cell cancer	0.000205	0.00155	CbGpPWpGaD
Celecoxib—CA6—Metabolism—CRABP1—germ cell cancer	0.000205	0.00155	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—CRABP1—germ cell cancer	0.000205	0.00155	CbGpPWpGaD
Celecoxib—Diarrhoea—Cisplatin—germ cell cancer	0.000205	0.000759	CcSEcCtD
Celecoxib—Alopecia—Methotrexate—germ cell cancer	0.000204	0.000757	CcSEcCtD
Celecoxib—Mental disorder—Methotrexate—germ cell cancer	0.000203	0.000751	CcSEcCtD
Celecoxib—PDPK1—Adaptive Immune System—FGF4—germ cell cancer	0.000202	0.00153	CbGpPWpGaD
Celecoxib—Hypersensitivity—Etoposide—germ cell cancer	0.000202	0.000749	CcSEcCtD
Celecoxib—PDPK1—ErbB1 downstream signaling—HRAS—germ cell cancer	0.000199	0.00151	CbGpPWpGaD
Celecoxib—PDPK1—Disease—SLC2A3—germ cell cancer	0.000197	0.0015	CbGpPWpGaD
Celecoxib—Dysgeusia—Methotrexate—germ cell cancer	0.000197	0.00073	CcSEcCtD
Celecoxib—Asthenia—Etoposide—germ cell cancer	0.000197	0.000729	CcSEcCtD
Celecoxib—PDPK1—VEGFA-VEGFR2 Pathway—HRAS—germ cell cancer	0.000196	0.00149	CbGpPWpGaD
Celecoxib—Back pain—Methotrexate—germ cell cancer	0.000195	0.000721	CcSEcCtD
Celecoxib—PDPK1—Immune System—PVRL2—germ cell cancer	0.000194	0.00147	CbGpPWpGaD
Celecoxib—Pruritus—Etoposide—germ cell cancer	0.000194	0.000719	CcSEcCtD
Celecoxib—MAPK14—Signaling by NGF—FGF4—germ cell cancer	0.000192	0.00146	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—CRABP1—germ cell cancer	0.000191	0.00145	CbGpPWpGaD
Celecoxib—MAPK14—TSH signaling pathway—MYC—germ cell cancer	0.000191	0.00145	CbGpPWpGaD
Celecoxib—Vomiting—Cisplatin—germ cell cancer	0.00019	0.000705	CcSEcCtD
Celecoxib—CYP2D6—brain—germ cell cancer	0.00019	0.00115	CbGeAlD
Celecoxib—Vision blurred—Methotrexate—germ cell cancer	0.00019	0.000703	CcSEcCtD
Celecoxib—MAPK14—Rac1/Pak1/p38/MMP-2 pathway—MYC—germ cell cancer	0.000189	0.00143	CbGpPWpGaD
Celecoxib—Rash—Cisplatin—germ cell cancer	0.000189	0.000699	CcSEcCtD
Celecoxib—Dermatitis—Cisplatin—germ cell cancer	0.000189	0.000699	CcSEcCtD
Celecoxib—Diarrhoea—Etoposide—germ cell cancer	0.000188	0.000695	CcSEcCtD
Celecoxib—MAPK14—Gene Expression—NR0B1—germ cell cancer	0.000187	0.00142	CbGpPWpGaD
Celecoxib—ALB—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000186	0.00141	CbGpPWpGaD
Celecoxib—Anaemia—Methotrexate—germ cell cancer	0.000186	0.000689	CcSEcCtD
Celecoxib—PDPK1—Signaling by VEGF—HRAS—germ cell cancer	0.000185	0.00141	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by Insulin receptor—HRAS—germ cell cancer	0.000184	0.0014	CbGpPWpGaD
Celecoxib—ALB—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000184	0.00139	CbGpPWpGaD
Celecoxib—PTGS2—C-MYB transcription factor network—KIT—germ cell cancer	0.000183	0.00139	CbGpPWpGaD
Celecoxib—MAPK14—Cellular responses to stress—H2AFZ—germ cell cancer	0.000183	0.00139	CbGpPWpGaD
Celecoxib—Dizziness—Etoposide—germ cell cancer	0.000181	0.000672	CcSEcCtD
Celecoxib—Vertigo—Methotrexate—germ cell cancer	0.000181	0.00067	CcSEcCtD
Celecoxib—Leukopenia—Methotrexate—germ cell cancer	0.00018	0.000668	CcSEcCtD
Celecoxib—Nausea—Cisplatin—germ cell cancer	0.000178	0.000659	CcSEcCtD
Celecoxib—CA12—Metabolism—CRABP1—germ cell cancer	0.000177	0.00134	CbGpPWpGaD
Celecoxib—MAPK14—IL2-mediated signaling events—HRAS—germ cell cancer	0.000176	0.00134	CbGpPWpGaD
Celecoxib—CA4—Metabolism—SLC2A3—germ cell cancer	0.000176	0.00134	CbGpPWpGaD
Celecoxib—Cough—Methotrexate—germ cell cancer	0.000176	0.000651	CcSEcCtD
Celecoxib—Vomiting—Etoposide—germ cell cancer	0.000174	0.000646	CcSEcCtD
Celecoxib—CA4—Metabolism—SLC22A3—germ cell cancer	0.000173	0.00132	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—OXT—germ cell cancer	0.000173	0.00131	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—KITLG—germ cell cancer	0.000173	0.00131	CbGpPWpGaD
Celecoxib—Rash—Etoposide—germ cell cancer	0.000173	0.000641	CcSEcCtD
Celecoxib—Dermatitis—Etoposide—germ cell cancer	0.000173	0.00064	CcSEcCtD
Celecoxib—MAPK14—p53 pathway—TP53—germ cell cancer	0.000172	0.0013	CbGpPWpGaD
Celecoxib—Headache—Etoposide—germ cell cancer	0.000172	0.000637	CcSEcCtD
Celecoxib—Arthralgia—Methotrexate—germ cell cancer	0.000171	0.000635	CcSEcCtD
Celecoxib—Myalgia—Methotrexate—germ cell cancer	0.000171	0.000635	CcSEcCtD
Celecoxib—Chest pain—Methotrexate—germ cell cancer	0.000171	0.000635	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.00017	0.000631	CcSEcCtD
Celecoxib—MAPK14—Developmental Biology—SOX2—germ cell cancer	0.000169	0.00128	CbGpPWpGaD
Celecoxib—CA2—Metabolism—SLC2A3—germ cell cancer	0.000169	0.00128	CbGpPWpGaD
Celecoxib—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—germ cell cancer	0.000167	0.00126	CbGpPWpGaD
Celecoxib—CA2—Metabolism—SLC22A3—germ cell cancer	0.000166	0.00126	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—KITLG—germ cell cancer	0.000166	0.00126	CbGpPWpGaD
Celecoxib—MAPK14—p73 transcription factor network—MYC—germ cell cancer	0.000166	0.00126	CbGpPWpGaD
Celecoxib—Confusional state—Methotrexate—germ cell cancer	0.000166	0.000614	CcSEcCtD
Celecoxib—MAPK14—Kit receptor signaling pathway—HRAS—germ cell cancer	0.000164	0.00125	CbGpPWpGaD
Celecoxib—Anaphylactic shock—Methotrexate—germ cell cancer	0.000164	0.000609	CcSEcCtD
Celecoxib—PTGS2—Aryl Hydrocarbon Receptor—MYC—germ cell cancer	0.000163	0.00124	CbGpPWpGaD
Celecoxib—Infection—Methotrexate—germ cell cancer	0.000163	0.000605	CcSEcCtD
Celecoxib—Nausea—Etoposide—germ cell cancer	0.000163	0.000604	CcSEcCtD
Celecoxib—MAPK14—Gene Expression—DNMT3L—germ cell cancer	0.000162	0.00123	CbGpPWpGaD
Celecoxib—Nervous system disorder—Methotrexate—germ cell cancer	0.000161	0.000597	CcSEcCtD
Celecoxib—Thrombocytopenia—Methotrexate—germ cell cancer	0.000161	0.000596	CcSEcCtD
Celecoxib—Skin disorder—Methotrexate—germ cell cancer	0.00016	0.000591	CcSEcCtD
Celecoxib—MAPK14—Oncostatin M Signaling Pathway—TP53—germ cell cancer	0.000159	0.00121	CbGpPWpGaD
Celecoxib—Hyperhidrosis—Methotrexate—germ cell cancer	0.000159	0.000588	CcSEcCtD
Celecoxib—PDPK1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—germ cell cancer	0.000158	0.0012	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—KITLG—germ cell cancer	0.000158	0.0012	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by SCF-KIT—HRAS—germ cell cancer	0.000158	0.00119	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—OXT—germ cell cancer	0.000157	0.00119	CbGpPWpGaD
Celecoxib—Anorexia—Methotrexate—germ cell cancer	0.000157	0.00058	CcSEcCtD
Celecoxib—MAPK14—Endothelins—HRAS—germ cell cancer	0.000156	0.00118	CbGpPWpGaD
Celecoxib—MAPK14—Rac1/Pak1/p38/MMP-2 pathway—TP53—germ cell cancer	0.000155	0.00118	CbGpPWpGaD
Celecoxib—PDPK1—BDNF signaling pathway—HRAS—germ cell cancer	0.000155	0.00117	CbGpPWpGaD
Celecoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—FGFR3—germ cell cancer	0.000152	0.00116	CbGpPWpGaD
Celecoxib—MAPK14—Oncostatin M Signaling Pathway—HRAS—germ cell cancer	0.000152	0.00115	CbGpPWpGaD
Celecoxib—PDPK1—Downstream signaling of activated FGFR—HRAS—germ cell cancer	0.000151	0.00114	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—RARS—germ cell cancer	0.00015	0.00114	CbGpPWpGaD
Celecoxib—MAPK14—TSH signaling pathway—HRAS—germ cell cancer	0.00015	0.00114	CbGpPWpGaD
Celecoxib—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.00015	0.000555	CcSEcCtD
Celecoxib—Insomnia—Methotrexate—germ cell cancer	0.000149	0.000551	CcSEcCtD
Celecoxib—MAPK14—Rac1/Pak1/p38/MMP-2 pathway—HRAS—germ cell cancer	0.000148	0.00113	CbGpPWpGaD
Celecoxib—MAPK14—BCR signaling pathway—HRAS—germ cell cancer	0.000148	0.00113	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by ERBB4—HRAS—germ cell cancer	0.000148	0.00113	CbGpPWpGaD
Celecoxib—Paraesthesia—Methotrexate—germ cell cancer	0.000147	0.000547	CcSEcCtD
Celecoxib—Dyspnoea—Methotrexate—germ cell cancer	0.000146	0.000543	CcSEcCtD
Celecoxib—Somnolence—Methotrexate—germ cell cancer	0.000146	0.000541	CcSEcCtD
Celecoxib—ALB—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000145	0.0011	CbGpPWpGaD
Celecoxib—Dyspepsia—Methotrexate—germ cell cancer	0.000145	0.000536	CcSEcCtD
Celecoxib—MAPK14—CDC42 signaling events—HRAS—germ cell cancer	0.000143	0.00109	CbGpPWpGaD
Celecoxib—Decreased appetite—Methotrexate—germ cell cancer	0.000143	0.000529	CcSEcCtD
Celecoxib—PDPK1—Insulin Signaling—HRAS—germ cell cancer	0.000142	0.00108	CbGpPWpGaD
Celecoxib—CA9—Metabolism—SLC2A3—germ cell cancer	0.000142	0.00108	CbGpPWpGaD
Celecoxib—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000142	0.000526	CcSEcCtD
Celecoxib—PDPK1—Downstream signal transduction—HRAS—germ cell cancer	0.000142	0.00107	CbGpPWpGaD
Celecoxib—Fatigue—Methotrexate—germ cell cancer	0.000142	0.000525	CcSEcCtD
Celecoxib—CA4—Metabolism—CRABP1—germ cell cancer	0.000141	0.00107	CbGpPWpGaD
Celecoxib—PDPK1—EGF/EGFR Signaling Pathway—HRAS—germ cell cancer	0.000141	0.00107	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by FGFR—HRAS—germ cell cancer	0.000141	0.00107	CbGpPWpGaD
Celecoxib—MAPK14—B Cell Receptor Signaling Pathway—MYC—germ cell cancer	0.000141	0.00107	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by ERBB2—HRAS—germ cell cancer	0.00014	0.00106	CbGpPWpGaD
Celecoxib—CA9—Metabolism—SLC22A3—germ cell cancer	0.00014	0.00106	CbGpPWpGaD
Celecoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—KIT—germ cell cancer	0.00014	0.00106	CbGpPWpGaD
Celecoxib—PDPK1—DAP12 signaling—HRAS—germ cell cancer	0.00014	0.00106	CbGpPWpGaD
Celecoxib—PDPK1—Downstream signaling events of B Cell Receptor (BCR)—HRAS—germ cell cancer	0.000138	0.00104	CbGpPWpGaD
Celecoxib—MAPK14—Leptin signaling pathway—HRAS—germ cell cancer	0.000136	0.00103	CbGpPWpGaD
Celecoxib—CA2—Metabolism—CRABP1—germ cell cancer	0.000136	0.00103	CbGpPWpGaD
Celecoxib—Feeling abnormal—Methotrexate—germ cell cancer	0.000135	0.000502	CcSEcCtD
Celecoxib—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000134	0.000498	CcSEcCtD
Celecoxib—MAPK14—Glucocorticoid receptor regulatory network—TP53—germ cell cancer	0.000132	0.001	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by FGFR in disease—HRAS—germ cell cancer	0.000131	0.000996	CbGpPWpGaD
Celecoxib—PDPK1—Fc epsilon receptor (FCERI) signaling—HRAS—germ cell cancer	0.000131	0.000996	CbGpPWpGaD
Celecoxib—PDPK1—DAP12 interactions—HRAS—germ cell cancer	0.000131	0.000996	CbGpPWpGaD
Celecoxib—Urticaria—Methotrexate—germ cell cancer	0.00013	0.000484	CcSEcCtD
Celecoxib—PDPK1—Signaling by EGFR—HRAS—germ cell cancer	0.00013	0.000987	CbGpPWpGaD
Celecoxib—Abdominal pain—Methotrexate—germ cell cancer	0.00013	0.000481	CcSEcCtD
Celecoxib—Body temperature increased—Methotrexate—germ cell cancer	0.00013	0.000481	CcSEcCtD
Celecoxib—PDPK1—Signaling by EGFR in Cancer—HRAS—germ cell cancer	0.000129	0.000979	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—FGFR3—germ cell cancer	0.000129	0.000976	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by PDGF—HRAS—germ cell cancer	0.000128	0.000974	CbGpPWpGaD
Celecoxib—PTGS2—Aryl Hydrocarbon Receptor—HRAS—germ cell cancer	0.000128	0.000972	CbGpPWpGaD
Celecoxib—PDPK1—Focal Adhesion—HRAS—germ cell cancer	0.000124	0.000941	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—FGFR3—germ cell cancer	0.000124	0.000937	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—FGF4—germ cell cancer	0.000123	0.000931	CbGpPWpGaD
Celecoxib—PDPK1—B Cell Activation—HRAS—germ cell cancer	0.000122	0.000922	CbGpPWpGaD
Celecoxib—ABCC4—Ectoderm Differentiation—MYC—germ cell cancer	0.000121	0.000919	CbGpPWpGaD
Celecoxib—Hypersensitivity—Methotrexate—germ cell cancer	0.000121	0.000448	CcSEcCtD
Celecoxib—PDPK1—Transmission across Chemical Synapses—HRAS—germ cell cancer	0.000119	0.000903	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—AVP—germ cell cancer	0.000119	0.000901	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—KIT—germ cell cancer	0.000118	0.000896	CbGpPWpGaD
Celecoxib—Asthenia—Methotrexate—germ cell cancer	0.000118	0.000437	CcSEcCtD
Celecoxib—MAPK14—TCR Signaling Pathway—HRAS—germ cell cancer	0.000117	0.000889	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—FGFR3—germ cell cancer	0.000117	0.000889	CbGpPWpGaD
Celecoxib—PDPK1—NGF signalling via TRKA from the plasma membrane—HRAS—germ cell cancer	0.000116	0.000882	CbGpPWpGaD
Celecoxib—Pruritus—Methotrexate—germ cell cancer	0.000116	0.000431	CcSEcCtD
Celecoxib—CA9—Metabolism—CRABP1—germ cell cancer	0.000114	0.000866	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—KIT—germ cell cancer	0.000113	0.00086	CbGpPWpGaD
Celecoxib—PDPK1—Disease—FGF4—germ cell cancer	0.000113	0.000859	CbGpPWpGaD
Celecoxib—Diarrhoea—Methotrexate—germ cell cancer	0.000112	0.000417	CcSEcCtD
Celecoxib—MAPK14—B Cell Receptor Signaling Pathway—HRAS—germ cell cancer	0.00011	0.000838	CbGpPWpGaD
Celecoxib—MAPK14—TGF-beta Signaling Pathway—MYC—germ cell cancer	0.00011	0.000833	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—FGF4—germ cell cancer	0.000109	0.00083	CbGpPWpGaD
Celecoxib—Dizziness—Methotrexate—germ cell cancer	0.000109	0.000403	CcSEcCtD
Celecoxib—MAPK14—Senescence and Autophagy in Cancer—TP53—germ cell cancer	0.000108	0.000822	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—AVP—germ cell cancer	0.000108	0.000818	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—KIT—germ cell cancer	0.000108	0.000816	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—CD9—germ cell cancer	0.000106	0.000806	CbGpPWpGaD
Celecoxib—Vomiting—Methotrexate—germ cell cancer	0.000104	0.000387	CcSEcCtD
Celecoxib—MAPK14—Senescence and Autophagy in Cancer—HRAS—germ cell cancer	0.000104	0.000786	CbGpPWpGaD
Celecoxib—Rash—Methotrexate—germ cell cancer	0.000104	0.000384	CcSEcCtD
Celecoxib—Dermatitis—Methotrexate—germ cell cancer	0.000103	0.000383	CcSEcCtD
Celecoxib—Headache—Methotrexate—germ cell cancer	0.000103	0.000381	CcSEcCtD
Celecoxib—MAPK14—VEGFA-VEGFR2 Pathway—HRAS—germ cell cancer	0.000102	0.000774	CbGpPWpGaD
Celecoxib—PDPK1—Disease—H2AFZ—germ cell cancer	0.000101	0.000767	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—PVRL2—germ cell cancer	0.000101	0.000765	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—KITLG—germ cell cancer	0.000101	0.000765	CbGpPWpGaD
Celecoxib—PTGS2—C-MYB transcription factor network—MYC—germ cell cancer	0.000101	0.000764	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	9.89e-05	0.00075	CbGpPWpGaD
Celecoxib—MAPK14—Oxidative Stress Induced Senescence—TP53—germ cell cancer	9.81e-05	0.000744	CbGpPWpGaD
Celecoxib—Nausea—Methotrexate—germ cell cancer	9.75e-05	0.000362	CcSEcCtD
Celecoxib—ABCC4—Transmembrane transport of small molecules—AVP—germ cell cancer	9.65e-05	0.000732	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by VEGF—HRAS—germ cell cancer	9.64e-05	0.000731	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	9.47e-05	0.000718	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	9.33e-05	0.000708	CbGpPWpGaD
Celecoxib—PDPK1—Disease—KITLG—germ cell cancer	9.31e-05	0.000706	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—OXT—germ cell cancer	9.29e-05	0.000705	CbGpPWpGaD
Celecoxib—PDPK1—Neuronal System—HRAS—germ cell cancer	9.13e-05	0.000692	CbGpPWpGaD
Celecoxib—MAPK14—MAPK Signaling Pathway—MYC—germ cell cancer	9.06e-05	0.000687	CbGpPWpGaD
Celecoxib—MAPK14—TGF-beta Signaling Pathway—TP53—germ cell cancer	9.03e-05	0.000684	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—KITLG—germ cell cancer	8.99e-05	0.000682	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by NGF—HRAS—germ cell cancer	8.95e-05	0.000679	CbGpPWpGaD
Celecoxib—ALB—SLC-mediated transmembrane transport—AVP—germ cell cancer	8.6e-05	0.000652	CbGpPWpGaD
Celecoxib—CA9—Cellular responses to stress—TP53—germ cell cancer	8.59e-05	0.000652	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	8.18e-05	0.00062	CbGpPWpGaD
Celecoxib—ALB—Folate Metabolism—TP53—germ cell cancer	8.12e-05	0.000616	CbGpPWpGaD
Celecoxib—MAPK14—BDNF signaling pathway—HRAS—germ cell cancer	8.05e-05	0.000611	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	8e-05	0.000607	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—FGF4—germ cell cancer	7.93e-05	0.000602	CbGpPWpGaD
Celecoxib—PTGS2—C-MYB transcription factor network—HRAS—germ cell cancer	7.92e-05	0.0006	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—MYC—germ cell cancer	7.68e-05	0.000582	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—FGFR3—germ cell cancer	7.49e-05	0.000568	CbGpPWpGaD
Celecoxib—MAPK14—MAPK Signaling Pathway—TP53—germ cell cancer	7.44e-05	0.000564	CbGpPWpGaD
Celecoxib—MAPK14—Insulin Signaling—HRAS—germ cell cancer	7.4e-05	0.000561	CbGpPWpGaD
Celecoxib—MAPK14—EGF/EGFR Signaling Pathway—HRAS—germ cell cancer	7.33e-05	0.000556	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—H2AFZ—germ cell cancer	7.08e-05	0.000537	CbGpPWpGaD
Celecoxib—PDPK1—Disease—FGFR3—germ cell cancer	6.92e-05	0.000525	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—KIT—germ cell cancer	6.88e-05	0.000522	CbGpPWpGaD
Celecoxib—MAPK14—Cellular Senescence—TP53—germ cell cancer	6.86e-05	0.00052	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	6.72e-05	0.000509	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—FGFR3—germ cell cancer	6.68e-05	0.000507	CbGpPWpGaD
Celecoxib—PTGS2—Disease—SLC2A3—germ cell cancer	6.55e-05	0.000497	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	6.55e-05	0.000497	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—KITLG—germ cell cancer	6.52e-05	0.000494	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—FGF4—germ cell cancer	6.38e-05	0.000484	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—AVP—germ cell cancer	6.37e-05	0.000483	CbGpPWpGaD
Celecoxib—PDPK1—Disease—KIT—germ cell cancer	6.35e-05	0.000482	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—TP53—germ cell cancer	6.31e-05	0.000478	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—KIT—germ cell cancer	6.14e-05	0.000465	CbGpPWpGaD
Celecoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—HRAS—germ cell cancer	6.05e-05	0.000459	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—TP53—germ cell cancer	5.93e-05	0.00045	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—HRAS—germ cell cancer	5.67e-05	0.00043	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—H2AFZ—germ cell cancer	5.66e-05	0.000429	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—SLC2A3—germ cell cancer	5.48e-05	0.000416	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—SLC22A3—germ cell cancer	5.4e-05	0.00041	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—KITLG—germ cell cancer	5.24e-05	0.000397	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	5.22e-05	0.000396	CbGpPWpGaD
Celecoxib—MAPK14—Cellular responses to stress—TP53—germ cell cancer	5.18e-05	0.000393	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—HRAS—germ cell cancer	5.1e-05	0.000387	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—HRAS—germ cell cancer	4.9e-05	0.000372	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—FGFR3—germ cell cancer	4.84e-05	0.000367	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—OXT—germ cell cancer	4.83e-05	0.000366	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—HRAS—germ cell cancer	4.65e-05	0.000353	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—KIT—germ cell cancer	4.45e-05	0.000337	CbGpPWpGaD
Celecoxib—ALB—Metabolism—SLC2A3—germ cell cancer	4.44e-05	0.000336	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—CRABP1—germ cell cancer	4.4e-05	0.000334	CbGpPWpGaD
Celecoxib—ALB—Metabolism—SLC22A3—germ cell cancer	4.37e-05	0.000331	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—AVP—germ cell cancer	4.37e-05	0.000331	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	4.29e-05	0.000325	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—FGF4—germ cell cancer	4.12e-05	0.000313	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—FGFR3—germ cell cancer	3.89e-05	0.000295	CbGpPWpGaD
Celecoxib—PTGS2—Disease—FGF4—germ cell cancer	3.76e-05	0.000285	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—H2AFZ—germ cell cancer	3.68e-05	0.000279	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—SLC2A3—germ cell cancer	3.66e-05	0.000278	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—SLC2A3—germ cell cancer	3.63e-05	0.000275	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—SLC22A3—germ cell cancer	3.61e-05	0.000274	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—SLC22A3—germ cell cancer	3.58e-05	0.000271	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—KIT—germ cell cancer	3.57e-05	0.000271	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CRABP1—germ cell cancer	3.56e-05	0.00027	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—TP53—germ cell cancer	3.52e-05	0.000267	CbGpPWpGaD
Celecoxib—PDPK1—Disease—MYC—germ cell cancer	3.49e-05	0.000265	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—KITLG—germ cell cancer	3.39e-05	0.000257	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—HRAS—germ cell cancer	3.36e-05	0.000255	CbGpPWpGaD
Celecoxib—PTGS2—Disease—H2AFZ—germ cell cancer	3.36e-05	0.000255	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—AVP—germ cell cancer	3.31e-05	0.000251	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—HRAS—germ cell cancer	3.25e-05	0.000247	CbGpPWpGaD
Celecoxib—PTGS2—Disease—KITLG—germ cell cancer	3.09e-05	0.000234	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—TP53—germ cell cancer	3.08e-05	0.000234	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—HRAS—germ cell cancer	3e-05	0.000228	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—HRAS—germ cell cancer	2.97e-05	0.000225	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—HRAS—germ cell cancer	2.95e-05	0.000223	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CRABP1—germ cell cancer	2.94e-05	0.000223	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CRABP1—germ cell cancer	2.92e-05	0.000221	CbGpPWpGaD
Celecoxib—PDPK1—Disease—HRAS—germ cell cancer	2.74e-05	0.000208	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—HRAS—germ cell cancer	2.65e-05	0.000201	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—FGFR3—germ cell cancer	2.52e-05	0.000191	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—MYC—germ cell cancer	2.45e-05	0.000186	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—SLC2A3—germ cell cancer	2.4e-05	0.000182	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—SLC22A3—germ cell cancer	2.36e-05	0.000179	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—KIT—germ cell cancer	2.31e-05	0.000175	CbGpPWpGaD
Celecoxib—PTGS2—Disease—FGFR3—germ cell cancer	2.3e-05	0.000174	CbGpPWpGaD
Celecoxib—PTGS2—Disease—KIT—germ cell cancer	2.11e-05	0.00016	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—TP53—germ cell cancer	2.01e-05	0.000152	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—MYC—germ cell cancer	1.96e-05	0.000148	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CRABP1—germ cell cancer	1.92e-05	0.000146	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—HRAS—germ cell cancer	1.92e-05	0.000146	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—TP53—germ cell cancer	1.59e-05	0.000121	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—HRAS—germ cell cancer	1.54e-05	0.000117	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—HRAS—germ cell cancer	1.52e-05	0.000115	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—MYC—germ cell cancer	1.27e-05	9.64e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—MYC—germ cell cancer	1.16e-05	8.8e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—TP53—germ cell cancer	1.04e-05	7.92e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—HRAS—germ cell cancer	9.99e-06	7.57e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—HRAS—germ cell cancer	9.11e-06	6.91e-05	CbGpPWpGaD
